
About 10–15% of all instances of breast cancer are triple-negative breast cancer (TNBC), an uncommon yet aggressive and rapidly spreading cancer that lacks three typical receptors found in most breast cancers: estrogen receptors (ER), progesterone receptors (PR), and the HER2 protein. Globally, TNBC is the most common cause of death for females and the most aggressive type of metastatic cancer.
Timely treatment of Triple-negative breast Cancer is crucial for many possible reasons :
Traditional risk factors for all types of breast cancer, including lifestyle and environmental factors, also apply to triple-negative breast cancer. The exact causes of TNBC are not fully recognised, but several factors are involved in its development:
Causes
Risk Factors
Triple-negative breast cancer (TNBC) cannot be prevented, although there are lifestyle behaviours that can lower the risk. Here are some tips-
Medical professionals and researchers are still looking at novel approaches to treating TNBC. Recent clinical studies evaluate novel drug combinations and new approaches to current therapies. The following are a few current treatments:
Chemotherapy: Healthcare providers might combine chemotherapy and surgery to treat early-stage triple-negative breast cancer. Which might be given before the surgery to shrink the tumour size and also post-surgery to kill any remaining cancer cells and reduce the risk of recurrence.
Cost Start From USD 1000 - USD 6800Explore Options
Immunotherapy: Healthcare Providers may combine immunotherapy and chemotherapy to shrink the size of tumors before surgery.
Cost Start From USD 3000 - USD 13578Explore Options
Targeted Therapy: Treatments that target malignant cells may be combined with immunotherapy and chemotherapy. For instance, doctors might employ PARP inhibitors as a targeted therapy. Poly ADP ribose polymerase, or PARP for short, is a cellular enzyme that fixes damage to DNA.
Cost Start From USD 3500Explore Options
Lumpectomy: It is the removal of a small margin of the surrounding tissue of the breast. It is also known as breast-conserving surgery. A lumpectomy may be followed by radiation treatments to treat any residual cancer cells.
Mastectomy: It is the removal of the entire breast. Mastectomy is a treatment for patients with multiple, very aggressive, or large invasive ductal tumours in most advanced cases.
Cost Start From USD 6000 - USD 15000Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Bangkok, Thailand
Bangpakok 9 International Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Bangkok, Thailand
Bangkok Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Thailand has a 3-year survival rate of about 85% for triple-negative breast cancer (TNBC) in its early stages and 21% for metastatic TNBC.
Compared to other forms of breast cancer, triple-negative breast cancer (TNBC) is noticeably more aggressive. It has fewer therapeutic options, grows and spreads more quickly, and frequently has a worse prognosis. Because TNBC does not have estrogen, progesterone, or HER2 receptors like other breast tumors do, it cannot be treated with hormonal medicines or targeted therapy. This aggressive nature emphasizes how crucial early detection and timely treatment are.
When compared to other forms of breast cancer, triple-negative breast cancer typically grows and spreads more quickly. According to research, TNBC tumors have the potential to grow by 1% daily. In contrast, the daily growth rate of breast tumors that are HER2-positive is 0.859%.
The adverse effects vary from therapy to treatment. Furthermore, how each person responds to these side effects may vary. Inquire about the adverse impact of a particular therapy from your doctor. They will outline how they will assist you in managing them as well as what you may do to benefit yourself.
Recent advancements in the discovery of novel therapies, including as immunotherapy and PARP inhibitors, have improved the prognosis for TNBC. Existing treatments are being used in novel ways by medical researchers. The prognosis for triple-negative breast cancer is better the earlier medical professionals identify it, as is the case with most cancers.
The stage at which triple-negative breast cancer (TNBC) is diagnosed affects the survival rate. About 91% of people with localised TNBC, 66% of people with regional TNBC, and 12% of people with distant TNBC will survive for five years. All stages together have a 5-year survival rate of about 77%2. Improving outcomes requires early detection and timely treatment.
Yes, triple-negative breast cancer (TNBC) can cause irreparable harm, particularly if the disease is not identified and treated quickly. TNBC is an aggressive type of breast cancer that can cause more serious and reversible harm by swiftly spreading to lymph nodes and other body parts. In order to avoid irreparable harm and increase the likelihood of positive results, early detection and timely treatment are essential.
Surgery-specific recovery times in Thailand range from 1 to 2 weeks for lumpectomies to 4 to 8 weeks for mastectomy, which includes hospital stays, drain removal, and activity limitations.
Thailand has top-notch, JCI-accredited facilities, skilled oncologists, reasonably priced IBC care, and all-inclusive medical tourism assistance.
Choose a board-certified oncologist specialisation in breast cancer or a medical oncologist with top hospital affiliation, expertise in specific cancer types, and international training.
Yes, top oncology experts at prestigious hospitals are available to provide you with a second opinion regarding Triple-Negative Breast Cancer (TNBC) therapy in Thailand. Make an appointment for a consultation with hospital oncology departments and submit medical records for evaluation.